Status:
UNKNOWN
PRINTO (the Paediatric Rheumatology International Trials Organisation)
Lead Sponsor:
Institute of Child Health
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
All Genders
Up to 16 years
Brief Summary
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Any child with JIA who has gone into remission using methotrexate
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00415935
End Date
December 1 2006
Last Update
December 25 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology ICH
London, United Kingdom, WC1N 1EH